AAAAAA

   
Results: 1-24 |
Results: 24

Authors: Langer, O Dolle, F Valette, H Halldin, C Vaufrey, F Fuseau, C Coulon, C Ottaviani, M Nagren, K Bottlaender, M Maziere, B Crouzel, C
Citation: O. Langer et al., Synthesis of high-specific-radioactivity 4- and 6-[F-18]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart, BIO MED CH, 9(3), 2001, pp. 677-694

Authors: Holopainen, IE Metsahonkala, EL Kokkonen, H Parkkola, RK Manner, TE Nagren, K Korpi, ER
Citation: Ie. Holopainen et al., Decreased binding of [C-11]flumazenil in Angelman syndrome patients with GABA(A) receptor beta(3) subunit deletions, ANN NEUROL, 49(1), 2001, pp. 110-113

Authors: Sutinen, E Jyrkkio, S Gronroos, T Haaparanta, M Lehikoinen, P Nagren, K
Citation: E. Sutinen et al., Biodistribution of [C-11]methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo, EUR J NUCL, 28(7), 2001, pp. 847-854

Authors: Ukkonen, H Knuuti, J Katoh, C Iida, H Sipila, H Lehikoinen, P Nagren, K Voipio-Pulkki, LM
Citation: H. Ukkonen et al., Use of [C-11]acetate and [O-15]O-2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction, EUR J NUCL, 28(3), 2001, pp. 334-339

Authors: Pietila, M Malminiemi, K Ukkonen, H Saraste, M Nagren, K Lehikoinen, P Volpio-Pulkki, LM
Citation: M. Pietila et al., Reduced myocardial carbon-11 hydroxyephedrine retention is associated withpoor prognosis in chronic heart failure, EUR J NUCL, 28(3), 2001, pp. 373-376

Authors: Knuuti, J Takala, TO Nagren, K Sipila, H Turpeinen, AK Uusitupa, MIJ Nuutila, P
Citation: J. Knuuti et al., Myocardial fatty acid oxidation in patients with impaired glucose tolerance, DIABETOLOG, 44(2), 2001, pp. 184-187

Authors: Kaasinen, V Nagren, K Hietala, J Farde, L Rinne, JO
Citation: V. Kaasinen et al., Sex differences in extrastriatal dopamine D-2-like receptors in the human brain, AM J PSYCHI, 158(2), 2001, pp. 308-311

Authors: Langer, O Halldin, C Chou, YH Sandell, J Swahn, CG Nagren, K Perrone, R Berardi, F Leopoldo, M Farde, L
Citation: O. Langer et al., Carbon-11 PB-12: An attempt to visualize the dopamine D-4 receptor in the primate brain with positron emission tomography, NUCL MED BI, 27(8), 2000, pp. 707-714

Authors: Oikonen, V Allonen, T Nagren, K Kajander, J Hietala, J
Citation: V. Oikonen et al., Quantification of [carbonyl-C-11]WAY-100635 binding: Considerations on thecerebellum, NUCL MED BI, 27(5), 2000, pp. 483-486

Authors: Krasikova, R Fedorova, O Korsakov, M Nagren, K Maziere, B Halldin, C
Citation: R. Krasikova et al., A fast and convenient method for robotic preparation of [C-11]flumazenil avoiding HPLC purification, J LABEL C R, 43(6), 2000, pp. 613-621

Authors: Kamarainen, EL Kyllonen, T Airaksinen, A Lundkvist, C Yu, MX Nagren, K Sandell, J Langer, O Vepsalainen, J Hiltunen, J Bergstrom, K Lotjonen, S Jaakkola, T Halldin, C
Citation: El. Kamarainen et al., Preparation of [F-18]beta-CFT-FP and [C-11]beta-CFT-FP, selective radioligands for visualisation of the dopamine transporter using positron emission tomography (PET), J LABEL C R, 43(12), 2000, pp. 1235-1244

Authors: Nagren, K Sutinen, E Jyrkkio, S
Citation: K. Nagren et al., [N-methyl-C-11]MeAIB, a tracer for system A amino acid transport: Preparation from [C-11]methyl triflate and HPLC metabolite analysis of plasma samples after intravenous administration in man., J LABEL C R, 43(10), 2000, pp. 1013-1021

Authors: Vilkman, H Kajander, J Nagren, K Oikonen, V Syvalahti, E Hietala, J
Citation: H. Vilkman et al., Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis, EUR J NUCL, 27(11), 2000, pp. 1666-1673

Authors: Kaasinen, V Vilkman, H Hietala, J Nagren, K Helenius, H Olsson, H Farde, L Rinne, JO
Citation: V. Kaasinen et al., Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain, NEUROBIOL A, 21(5), 2000, pp. 683-688

Authors: Kaasinen, V Ruottinen, HM Nagren, K Lehikoinen, P Oikonen, T Rinne, JO
Citation: V. Kaasinen et al., Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone, J NUCL MED, 41(1), 2000, pp. 65-70

Authors: Kemppainen, N Ruottinen, H Nagren, K Rinne, JO
Citation: N. Kemppainen et al., PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD, NEUROLOGY, 55(2), 2000, pp. 205-209

Authors: Kaasinen, V Nagren, K Hietala, J Oikonen, V Vilkman, H Farde, L Halldin, C Rinne, JO
Citation: V. Kaasinen et al., Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease, NEUROLOGY, 54(7), 2000, pp. 1482-1487

Authors: Lamusuo, S Pitkanen, A Jutila, L Ylinen, A Partanen, K Kalviainen, R Ruottinen, HM Oikonen, V Nagren, K Lehikoinen, P Vapalahti, M Vainio, P Rinne, JO
Citation: S. Lamusuo et al., [C-11]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy - Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology, NEUROLOGY, 54(12), 2000, pp. 2252-2260

Authors: Ukkonen, H Saraste, M Akkila, J Knuuti, J Karanko, M Iida, H Lehikoinen, P Nagren, K Lehtonen, L Voipio-Pulkki, LM
Citation: H. Ukkonen et al., Myocardial efficiency during levosimendan infusion in congestive heart failure, CLIN PHARM, 68(5), 2000, pp. 522-531

Authors: Kanerva, H Vilkman, H Nagren, K Kilkku, O Kuoppamaki, M Syvalahti, E Hietala, J
Citation: H. Kanerva et al., Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study, PSYCHOPHAR, 145(1), 1999, pp. 76-81

Authors: Pohjalainen, T Nagren, K Syvalahti, EKG Hietala, J
Citation: T. Pohjalainen et al., The dopamine D-2 receptor 5 '-flanking variant, C-141 Ins/Del, is not associated with reduced dopamine D-2 receptor density in vivo, PHARMACOGEN, 9(4), 1999, pp. 505-509

Authors: Langer, O Nagren, K Dolle, F Lundkvist, C Sandell, J Swahn, CG Vaufrey, F Crouzel, C Maziere, B Halldin, C
Citation: O. Langer et al., Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand[C-11]raclopride from [C-11]methyl triflate, J LABEL C R, 42(12), 1999, pp. 1183-1193

Authors: Hietala, J Nagren, K Lehikoinen, P Ruotsalainen, U Syvalahti, E
Citation: J. Hietala et al., Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis, J CEREBR B, 19(2), 1999, pp. 210-217

Authors: Vesalainen, RK Pietila, M Tahvanainen, KUO Jartti, T Teras, M Nagren, K Lehikoinen, P Huupponen, R Ukkonen, H Saraste, M Knuuti, J Voipio-Pulkki, LM
Citation: Rk. Vesalainen et al., Cardiac positron emission tomography imaging with [C-11]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure, AM J CARD, 84(5), 1999, pp. 568-574
Risultati: 1-24 |